Fecal microbiota transplantation (FMT) -- extracting beneficial bacteria & yeasts from healthy donor feces & transplanting it into the colon of a recipient -- continues to be investigated as a possible treatment for #IBD.
This recently published study reviews "the key determinants of FMT success, insights & strategies that will enable a close integration of lab-based and clinical approaches for increasing FMT success."
#crohns #UC #ulcerativecolitis #FMT #IBD
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(23)00125-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1931312823001257%3Fshowall%3Dtrue

1 #IBDHorizons co-founder @IBD_Afzali
+
1 #IBDHorizons23 speaker @MRegueiroMD
————
🆓#IBD symposium talking latest on S1P receptor for #UlcerativeColitis

📅Mon, May 8
🏨Hyatt
🕰️6:00 CT
🧑‍💻Virtual avail
📄CME/MOC
🎟️http://bit.ly/TChicago23
#DDW2023 #WomenInGI #GITwitter #HereForDDW
---
RT @cQIme
@CWRU_GI @uc_health @IBDHorizons
@ScrubsNHeels @UCincyIM #WomenInGI #GITwitter #HereForDDW
https://twitter.com/cQIme/status/1654644067827961856

RT @OmarMTag
Join Dr. @MRegueiroMD and Dr. @IBD_Afzali at DDW and learn more about S1P receptor modulators 💊💊for #ulcerativecolitis #DDW2023 #GITwitter #MedTwitter 🔥🔥 https://twitter.com/ibd_afzali/status/1651382935608516608

RT @IBD_Afzali
Planning on #DDW2023, join @MRegueiroMD & me for a free #IBD symposium

Learn latest on S1P receptor modulators for #UlcerativeColitis

📅Mon, May 8
🏨Hyatt
🕰️6:00 CT
🧑‍💻Virtual avail
📄CME/MOC
🎟️http://bit.ly/TChicago23
#WomenInGI #GITwitter #HereForDDW

Planning on #DDW2023, join @MRegueiroMD & me for a free #IBD symposium

Learn latest on S1P receptor modulators for #UlcerativeColitis

📅Mon, May 8
🏨Hyatt
🕰️6:00 CT
🧑‍💻Virtual avail
📄CME/MOC
🎟️http://bit.ly/TChicago23
#WomenInGI #GITwitter #HereForDDW

RT @PeerView
Learn to explain how the therapeutic effects of sphingosine-1-phosphate (S1P) receptor modulators address the underlying pathophysiology of #IBD. 5/8 at 6:00 PM CDT during #DDW2023 featuring @MRegueiroMD & @IBD_Afzali https://bit.ly/TChicago23 #UlcerativeColitis #MedEd

RT @PeerView
Register today to meet our #IBD experts @MRegueiroMD & @IBD_Afzali during #DDW2023! Live online on May 8th at 5:30 PM CDT. https://bit.ly/TChicago23 #CrohnsDisease #UlcerativeColitis #MedEd #MedTwitter

RT @DoubleBagginIt
There is life on the other side of health hardships, surgeries and diagnoses. Find your people! You are NOT alone! #ibd #crohns #ulcerativecolitis #ostomy #ostomate
@CrohnsColitisFn @UOAA @TheMightySite @patientsrising @healthcentral @AmerGastroAssn @IBD_Afzali

RT @PeerView
Get the latest on individualized treatment using S1P receptor modulators for appropriate patients with #UlcerativeColitis in accordance with current evidence & guidelines 5/8 at 5:30 PM CDT during #DDW2023 with @MRegueiroMD & @IBD_Afzali: https://bit.ly/TChicago23 #MedEd

RT @rogeriosparra
@IBD_Afzali individualization of treatment may be the key to success in the long term! #crohn #ibd #ulcerativecolitis

RT @IBD_Afzali
Wonderful to return to Brazil 🇧🇷 and be a part of @JanssenGlobal to discuss Treatment Management in #Crohns #UlcerativeColitis alongside friends & colleagues @waqqasafif and Dra Cris Flores. And, always need to make time to spend with friends & enjoy cochinhas (my fav!) 😋

Wonderful to return to Brazil 🇧🇷 and be a part of @JanssenGlobal to discuss Treatment Management in #Crohns #UlcerativeColitis alongside friends & colleagues @waqqasafif and Dra Cris Flores. And, always need to make time to spend with friends & enjoy cochinhas (my fav!) 😋

RT @rogeriosparra
@IBD_Afzali individualization of treatment may be the key to success in the long term! #crohn #ibd #ulcerativecolitis

#IBDHorizons23

Dr #BrianFeagan brings us what’s come about in the studies that took place in 2022/23

💉VDZ treating pouchitis
💊Upa for #UlcerativeColitis
💉Risa approval
💊Combo return of golmumab/guselkumab
💉TL1A monoclonal for fibrostenosing #Crohns

RT @IBDHorizons
#SpeakerSpotlight

🥼@MaiaKayalMD leads Pacific Northwest #IBDHorizons23 6th session in Seattle!!

🎤Managing Complex #IBD as 2nd Opinion
📖A little about Dr Kayal

🔗FREE registration: http://ibdhorizons.org

#MedEd #Crohns #UlcerativeColitis #Gastroenterology #GITwitter

RT @IBDHorizons
#SpeakerSpotlight

🥼@tinahamd leads Pacific Northwest #IBDHorizons23 5th session in Seattle!!

🎤 Women's Health & #IBD
📖A little about Dr Ha

🆓🔗Must register: http://ibdhorizons.org

#MedEd #Crohns #UlcerativeColitis #Gastroenterology #GITwitter @MayoClinicGIHep

RT @IBDHorizons
#IBDHorizons23

What to expect from #jpouch/#IPAA surgery

🔷Colectomy is NOT a cure for #UlcerativeColitis, BUT 97% of patients are happy & living their life.
🔹Expect 3-9 BM/day
🔹Majority regain continence
🔹Before labeling a pouch to disease, make sure to recheck mechanics

RT @IBDHorizons
#IBDHorizons23
How would you answer this Q?

Reasons to consider surgical consult EXCEPT:
A-Persistent obstruction despite balloon dilation
B-Intractable #UlcerativeColitis bleeding/symptoms
C-SB strictures w/fistula
D-ASx stenosis with 1.5cm residual lumen & bowel dilation

RT @IBDHorizons
#IBDHorizons23

What defines “elderly” in #IBD in studies?

> 60/65 years of age is typically the description of elderly in IBD studies. ~ @IBD_Afzali

#Crohns #UlcerativeColitis

#IBDHorizons23

What to expect from #jpouch/#IPAA surgery

🔷Colectomy is NOT a cure for #UlcerativeColitis, BUT 97% of patients are happy & living their life.
🔹Expect 3-9 BM/day
🔹Majority regain continence
🔹Before labeling a pouch to disease, make sure to recheck mechanics